A system and method for pulsed electromagnetic fields (PEMF) tissue engineering enhances musculoskeletal tissue stimulation. A tissue engineering device may include both low and high pulse frequency signal generation components that may alternatively drive one or more coils to generate PEMFs. These PEMFs may be applied to bone tissue, tendons, ligaments, and/or cartilage. A prescribed treatment regimen using the tissue engineering device may include a first period of time where a first pulse frequency is used in treatment that supports tissue proliferation followed by a second period of time where a second pulse frequency (less than the first pulse frequency) is used in treatment that supports tissue differentiation. A treatment regimen may also include, with the frequency characteristic, applying a slew rate to the pulse characteristics that is on the order of around 30 to 100 Tesla per second to drive tissue differentiation in a targeted manner.

A method for treating back pain in a patient in need of such treatment is provided. The method includes positioning a balloon catheter in or adjacent to a treatment zone containing a basivertebral nerve. A chemical denervation agent is administered with the balloon catheter such that the chemical denervation agent chemically ablates at least a portion of the basivertebral nerve, Kits, systems and methods are disclosed.

A system and method for performing a radiofrequency (RF) ablation procedure with a cooled RF probe includes measuring one or more local perfusion characteristics at an ablation site within a patient. The method also includes determining a heat transfer due to local perfusion at the ablation site based on the one or more local perfusion characteristics. Further, the method includes determining an operating threshold for the cooled RF probe based, at least in part, on the heat transfer. Moreover, the method includes controlling the cooled RF probe based on the operating threshold to create a lesion at the ablation site within the patient.

A cooled radiofrequency ablation system including a probe assembly having a proximal region, a distal tip region, and a shaft is provided. First and second internal cooling fluid tubes extend from the proximal region and are positioned inside a cavity defined by the shaft. The distal tip region includes a conductive portion for delivering energy to a target location within tissue. The system also includes a radiofrequency generator for delivering energy to the target location and a cooling fluid reservoir and a bidirectional pump assembly for circulating a cooling fluid from the reservoir through the first internal cooling fluid tube then the second internal cooling fluid tube when the pump operates in a first direction or through the second internal cooling fluid tube then the first internal cooling fluid tube when the pump operates in a second direction to form lesions of different sizes at the target location.

A system for delivering energy to a patient's body includes a plurality of probes for delivering at least one of electrical or radiofrequency energy to the patient's body and a controller communicatively coupled to the plurality of probes and configured to present a display including a collapsible control panel that overlays a plurality of independent control panels each indicating one or more real-time operating parameters associated with the plurality of probes. The collapsible control panel includes a first graphical element for starting a treatment procedure for all of the plurality of probes simultaneously and a second graphical element that, when selected by the user, causes the display to dynamically update by closing the collapsible control panel to present third graphical elements in each of the plurality of independent control panels, the third graphical elements configured to start an individual treatment procedure for an associated one of the plurality of probes.

Described herein are various implementations of systems and methods for accessing and modulating tissue (for example, systems and methods for accessing and ablating nerves or other tissue within or surrounding a vertebral body to treat chronic lower back pain). Assessment of vertebral endplate degeneration or defects (e.g., pre-Modic changes) to facilitate identification of treatment sites and protocols are also provided in several embodiments. Several embodiments comprise the use of biomarkers to confirm or otherwise assess ablation, pain relief, efficacy of treatment, etc. Some embodiments include robotic elements for, as an example, facilitating robotically controlled access, navigation, imaging, and/or treatment.

A surgical system includes a robotic device, and a surgical tool coupled to the robotic device and comprising a distal end. The system further includes a neural monitor configured to generate an electrical signal and apply the electrical signal to the distal end of the surgical tool, wherein the electrical signal causes innervation of a first portion of a patient's anatomy which generates an electromyographic signal, and a sensor configured to measure the electromyographic signal. The neural monitor is configured to determine a distance between the distal end of the surgical tool and a portion of nervous tissue based on the electrical signal and the electromyographic signal, and cause feedback to be provided to a user based on the distance.

Described herein are various implementations of systems and methods for accessing and modulating tissue (for example, systems and methods for accessing and ablating nerves or other tissue within or surrounding a vertebral body to treat chronic lower back pain). Assessment of vertebral endplate degeneration or defects (e.g., pre-Modic changes) to facilitate identification of treatment sites and protocols are also provided in several embodiments. Several embodiments comprise the use of biomarkers to confirm or otherwise assess ablation, pain relief, efficacy of treatment, etc. Some embodiments include robotic elements for, as an example, facilitating robotically-controlled access, navigation, imaging, and/or treatment.

A system and method for pulsed electromagnetic fields (PEMF) tissue engineering enhances musculoskeletal tissue stimulation. A tissue engineering device may include both low and high pulse frequency signal generation components that may alternatively drive one or more coils to generate PEMFs. These PEMFs may be applied to bone tissue, tendons, ligaments, and/or cartilage. A prescribed treatment regimen using the tissue engineering device may include a first period of time where a first pulse frequency is used in treatment that supports tissue proliferation followed by a second period of time where a second pulse frequency (less than the first pulse frequency) is used in treatment that supports tissue differentiation. A treatment regimen may also include, with the frequency characteristic, applying a slew rate to the pulse characteristics that is on the order of around 30 to 100 Tesla per second to drive tissue differentiation in a targeted manner.

Methods and apparatuses (systems, devices, etc.) for treating biological tissue to evoke one or more desirable biological and/or physiological effects using pulsed electric fields in the sub-microsecond range at very low electric field strength (e.g., less than 1 kV/cm) but at high (e.g., megahertz) frequencies.